AP Biosciences Inc (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 121.00
+1.50 (1.24%)
Sep 5, 2025, 1:51 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 10.43 billion as of September 5, 2025. Its market cap has increased by 194.91% in one year.
Market Cap
10.43B
Enterprise Value
9.13B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
121.00
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 10.43B, an increase of 104.61%. That is a compound annual growth rate of 39.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 10.43B | 146.89% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 395.51B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 90.84B |
| Lotus Pharmaceutical | 50.62B |
| Lumosa Therapeutics | 40.77B |
| Oneness Biotech | 36.44B |
| Polaris Group | 29.47B |
| Center Laboratories | 28.63B |